The health ministry has lifted the ban on retail sale of oxytocin, an essential drug used to prevent and treat bleeding after child birth, but imposed strict regulations on its sales. The new rules also stated that with effect from September 1, 2018, oxytocin will be moved from schedule H to schedule H1.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/2BDTefA
No comments:
Post a Comment